For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Abeona Therapeutics Inc’s stock clocked out at $5.85, up 0.34% from its previous closing price of $5.83. In other words, the price has increased by $0.34 from its previous closing price. On the day, 0.59 million shares were traded. ABEO stock price reached its highest trading level at $5.875 during the session, while it also had its lowest trading level at $5.7117.
Ratios:
To gain a deeper understanding of ABEO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.90 and its Current Ratio is at 4.90. In the meantime, Its Debt-to-Equity ratio is 0.58 whereas as Long-Term Debt/Eq ratio is at 0.37.
On March 05, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $16.
On July 03, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.H.C. Wainwright initiated its Buy rating on July 03, 2024, with a $15 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jul 09 ’25 when Silverstein Christine Berni sold 13,093 shares for $5.86 per share. The transaction valued at 76,669 led to the insider holds 120,479 shares of the business.
Seshadri Vishwas sold 69,420 shares of ABEO for $406,503 on Jul 09 ’25. The Chief Executive Officer now owns 1,234,341 shares after completing the transaction at $5.86 per share. On Jul 09 ’25, another insider, Vazzano Joseph Walter, who serves as the Chief Financial Officer of the company, sold 25,411 shares for $5.86 each. As a result, the insider received 148,799 and left with 479,168 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ABEO now has a Market Capitalization of 300293376 and an Enterprise Value of 230392256.
Stock Price History:
The Beta on a monthly basis for ABEO is 1.53, which has changed by 0.061705947 over the last 52 weeks, in comparison to a change of 0.11844492 over the same period for the S&P500. Over the past 52 weeks, ABEO has reached a high of $7.32, while it has fallen to a 52-week low of $3.93. The 50-Day Moving Average of the stock is -3.10%, while the 200-Day Moving Average is calculated to be 1.27%.
Shares Statistics:
It appears that ABEO traded 1.85M shares on average per day over the past three months and 1455630 shares per day over the past ten days. A total of 48.95M shares are outstanding, with a floating share count of 45.31M. Insiders hold about 11.43% of the company’s shares, while institutions hold 59.19% stake in the company. Shares short for ABEO as of 1749772800 were 6462782 with a Short Ratio of 3.50, compared to 1747267200 on 5892747. Therefore, it implies a Short% of Shares Outstanding of 6462782 and a Short% of Float of 13.520001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
